Corvus PharmaceuticalsCRVS
13F holders, Q3 2024 (September 30)62holders +15
18new positions
3sold out
4famous investors
$5.28avg. 13F price*
At the end of Q3 2024, 62 institutions reported holding Corvus Pharmaceuticals Inc. (CRVS) in their 13F filings, up 15 from Q2 2024. 18 opened new positions and 3 sold out. The largest holders were Orbimed Advisors LLC ($36.7M), Point72 Asset Management ($29.4M) and Samlyn Capital, LLC ($23.9M). 4 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Corvus Pharmaceuticals Inc.
- CUSIP
- 221015100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $17.0M |
| Exits | 3 | $62K |
All 13F filers, Q2 2024 → Q3 2024: 4,952,009 shares bought and 2,559,306 shares sold, net +2,392,703 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 62 holders
| Orbimed Advisors LLC | 0.67% | No change | 6,943,654 | $36.7M |
| Point72 Asset Management | 0.10% | Reduce -6.7% | 5,562,729 | $29.4M |
| Samlyn Capital, LLC | 0.39% | Reduce -26.0% | 4,530,333 | $23.9M |
| Adams Street Partners LLC | 9.52% | No change | 3,275,616 | $17.3M |
| Vanguard Group Inc. | 0.00% | Add +46.7% | 2,420,619 | $12.8M |
| Vivo Capital, LLC | 0.65% | New | 1,497,268 | $7.9M |
| BlackRock, Inc. | 0.00% | — | 603,877 | $3.2M |
| Geode Capital Management, LLC | 0.00% | Add +22.4% | 563,009 | $3.0M |
| Ghost Tree Capital, LLC | 0.90% | New | 500,000 | $2.6M |
| Morgan Stanley | 0.00% | Add +5.9% | 393,262 | $2.1M |
| Renaissance Technologies | 0.00% | Reduce -31.4% | 386,588 | $2.0M |
| Goldman Sachs Group Inc. | 0.00% | New | 376,121 | $2.0M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 331,360 | $1.7M |
| Marshall Wace, LLP | 0.00% | Add +333.5% | 323,211 | $1.7M |
| Millennium Management | 0.00% | Add +52.1% | 311,288 | $1.6M |
| Susquehanna International Group, LLP | 0.00% | Add +753.6% | 218,962 | $1.2M |
| State Street Corp. | 0.00% | Add +48.2% | 178,246 | $941K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +64.7% | 137,031 | $724K |
| Qube Research & Technologies Ltd | 0.00% | New | 127,332 | $672K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 127,300 | $672K |
| Citigroup Inc. | 0.00% | New | 122,858 | $649K |
| Towerview LLC | 0.40% | Reduce -70.6% | 117,500 | $620K |
| Northern Trust Corp. | 0.00% | Add +27.1% | 105,450 | $557K |
| Citadel Advisors | 0.00% | Add +83.1% | 97,073 | $513K |
| Acadian Asset Management LLC | 0.00% | New | 79,735 | $420K |
| Two Sigma Investments, LP | 0.00% | Add +49.7% | 71,552 | $378K |
| Jackson Square Capital, LLC | 0.08% | No change | 63,773 | $337K |
| Two Sigma Advisers, LP | 0.00% | Reduce -45.9% | 61,300 | $324K |
| Jane Street Group, LLC | 0.00% | New | 50,221 | $265K |
| Hikari Power Ltd | 0.02% | No change | 49,959 | $264K |
| JPMorgan Chase & Co. | 0.00% | Add +441.5% | 49,556 | $262K |
| Mission Wealth Management, LP | 0.01% | New | 40,000 | $211K |
| Avity Investment Management Inc. | 0.01% | Add +138.2% | 27,580 | $146K |
| Ancora Advisors LLC | 0.00% | New | 23,285 | $123K |
| Quinn Opportunity Partners LLC | 0.01% | No change | 22,327 | $118K |
| Commerce Bank | 0.00% | No change | 20,000 | $106K |
| American Century Companies Inc. | 0.00% | Reduce -0.2% | 18,208 | $96K |
| Oppenheimer & Co. Inc. | 0.00% | New | 16,947 | $89K |
| Osaic Holdings, Inc. | 0.00% | Add +3033.7% | 16,734 | $88K |
| Virtu Financial LLC | 0.00% | New | 15,694 | $83K |
| UBS Group AG | 0.00% | Add +20.6% | 15,681 | $83K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 15,668 | $83K |
| XTX Topco Ltd | 0.01% | New | 14,086 | $74K |
| Squarepoint Ops LLC | 0.00% | New | 12,080 | $64K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,924 | $63K |
| Whittier Trust Co. of Nevada Inc. | 0.00% | No change | 11,200 | $59K |
| Nwam LLC | 0.00% | New | 10,050 | $53K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -58.9% | 10,026 | $53K |
| Masso Torrence Wealth Management Inc. | 0.03% | No change | 10,000 | $53K |
| OneDigital Investment Advisors LLC | 0.00% | Reduce -31.3% | 10,000 | $53K |
| Rothschild Investment LLC | 0.00% | No change | 7,000 | $37K |
| Group One Trading LLC | 0.00% | New | 5,560 | $29K |
| Simplex Trading, LLC | 0.00% | Add +156.3% | 5,670 | $29K |
| Northwest Capital Management Inc | 0.01% | No change | 3,397 | $18K |
| BNP Paribas Financial Markets | 0.00% | New | 3,110 | $16K |
| Western Pacific Wealth Management, LP | 0.01% | New | 2,000 | $11K |
| Rhumbline Advisers | 0.00% | No change | 791 | $4K |
| Bank of America Corp. | 0.00% | Add +4.3% | 409 | $2K |
| IFP Advisors, Inc | 0.00% | No change | 24 | $127 |
| Parallel Advisors, LLC | 0.00% | No change | 20 | $106 |
| FMR LLC | 0.00% | Reduce -81.1% | 10 | $51 |
| Barclays PLC | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is CRVS's weight in each manager's 13F, not the share of Corvus Pharmaceuticals Inc. the manager owns.